当前位置:首页 - 行情中心 - 永安药业(002365) - 财务分析 - 现金流量表

永安药业

(002365)

  

流通市值:30.02亿  总市值:36.01亿
流通股本:2.46亿   总股本:2.95亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金824,860,579.17483,806,723.73196,635,490.26832,727,212.11
  收到的税费返还25,163,063.6316,639,628.948,067,644.8123,469,372.92
  收到其他与经营活动有关的现金10,110,422.527,452,147.01884,219.6514,435,234.24
  经营活动现金流入小计860,134,065.32507,898,499.68205,587,354.72870,631,819.27
  购买商品、接受劳务支付的现金614,811,435.83364,014,363.83148,034,050.03534,171,092.27
  支付给职工以及为职工支付的现金99,670,067.8770,031,298.5140,166,984.63119,341,802.86
  支付的各项税费28,229,660.4418,403,911.826,113,412.9923,539,264.06
  支付其他与经营活动有关的现金34,333,226.0823,358,430.6212,704,683.3454,496,241.14
  经营活动现金流出小计777,044,390.22475,808,004.78207,019,130.99731,548,400.33
  经营活动产生的现金流量净额83,089,675.132,090,494.9-1,431,776.27139,083,418.94
二、投资活动产生的现金流量:
  收回投资收到的现金788,752,978.49507,271,232.56253,891,659.541,057,033,842.43
  取得投资收益收到的现金13,958,340.278,086,203.914,405,420.5328,009,702.24
  处置固定资产、无形资产和其他长期资产收回的现金净额386,114368,290-364,095.8
  投资活动现金流入小计803,097,432.76515,725,726.47258,297,080.071,085,407,640.47
  购建固定资产、无形资产和其他长期资产支付的现金159,607,322.888,019,094.4541,433,774.6562,277,086.93
  投资支付的现金697,899,740.38456,899,305.84191,296,918.191,143,180,134.33
  投资活动现金流出小计857,507,063.18544,918,400.29232,730,692.841,205,457,221.26
  投资活动产生的现金流量净额-54,409,630.42-29,192,673.8225,566,387.23-120,049,580.79
三、筹资活动产生的现金流量:
  吸收投资收到的现金---2,500,000
  取得借款收到的现金---15,000,000
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---17,500,000
  偿还债务支付的现金---54,500,000
  分配股利、利润或偿付利息支付的现金28,820,340.0228,818,288.63-29,882,099.32
  支付其他与筹资活动有关的现金---43,292,817.54
  筹资活动现金流出平衡项目00-0
  筹资活动现金流出小计28,820,340.0228,818,288.63-127,674,916.86
  筹资活动产生的现金流量净额平衡项目00-0
  筹资活动产生的现金流量净额-28,820,340.02-28,818,288.63--110,174,916.86
四、汇率变动对现金及现金等价物的影响-5,375,997.4-3,209,054.82-1,506,585.831,321,512.16
五、现金及现金等价物净增加额-5,516,292.74-29,129,522.3722,628,025.13-89,819,566.55
  加:期初现金及现金等价物余额230,585,726.41230,585,726.41230,585,726.41320,405,292.96
  期末现金及现金等价物余额225,069,433.67201,456,204.04253,213,751.54230,585,726.41
补充资料:
  净利润-42,784,942.19-7,190,064.51
  资产减值准备-3,242.04-16,527,392.86
  固定资产和投资性房地产折旧-54,684,383.33-113,332,466.25
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-54,684,383.33-113,332,466.25
  无形资产摊销-1,723,955.16-3,504,499.84
  处置固定资产、无形资产和其他长期资产的损失--8,229.04--185,682.47
  固定资产报废损失-1,015,312.76-185,454.28
  公允价值变动损失-3,416,124.22-1,085,650.93
  财务费用-6,226,072.41-941,505.85
  投资损失--9,315,453.45--30,560,208.94
  递延所得税-3,434,893.22--10,816,976.04
  其中:递延所得税资产减少-7,728,709.08--5,570,985.66
    递延所得税负债增加--4,293,815.86--5,245,990.38
  存货的减少--10,009,890.65-3,631,426.79
  经营性应收项目的减少--93,531,606.79-39,577,796.94
  经营性应付项目的增加-24,621,833.51--5,205,748.18
  其他--11,392.76--
  现金的期末余额-201,456,204.04-230,585,726.41
  减:现金的期初余额-230,585,726.41-320,405,292.96
  现金及现金等价物的净增加额--29,129,522.37--89,819,566.55
公告日期2026-10-302026-08-282026-04-302026-04-17
审计意见(境内)标准无保留意见
TOP↑